Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Extended Range HRP Microwell Substrate Launched

By LabMedica International staff writers
Posted on 18 Jul 2012
AACC 2012: An extended range horseradish peroxidase (HRP) microwell substrate was launched at the American Association for Clinical Chemistry (AACC) show in Los Angeles (CA, USA), taking place from July 15-19, 2012.

A product of SurModics (Eden Prairie, MN, USA), the BioFX TMB extended range HRP microwell substrate (TMBX), when used in a quantitative assay, increases the assay's upper limit of quantization and maintains the detection limits and analytical sensitivity achieved with other TMB substrates. More...
TMBX also improves the reproducibility of the assay through lower backgrounds and better control of assay timing.

TMBX is SurModic's slowest kinetic option of TMB substrates for extended dynamic range and improved reproducibility within. It is a colorimetric substrate for HRP detection in microwell applications. TMBX is a one-component substrate that requires no preparation prior to use.

The right substrate can make a substantial contribution to the overall sensitivity of an assay. SurModics offers a variety of colorimetric TMB substrates and complementary novel stop solutions, available in both bulk and custom dispenses.

SurModics' offers new surface modification technologies and in vitro diagnostic chemical components. Core offerings include surface modification coating technologies that impart lubricity, prohealing, and biocompatibility capabilities, and components for in vitro diagnostic tests and microarrays.

Related Links:

SurModics




New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
New
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A simple blood sample that allows DNA methylation could identify epigenetic biomarkers (Photo courtesy of 123RF)

Simple Blood Sample Could Identify Epigenetic Biomarkers to Predict CVD Risk in Type 2 Diabetes

People with type 2 diabetes face up to four times higher risk of cardiovascular events such as heart attacks, strokes, and angina compared to individuals without the condition. Yet, current tools used... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The new technology could predict who will benefit from immunotherapy (Photo courtesy of Max Delbrück Center)

New Technology Deciphers Immune Cell Communication to Predict Immunotherapy Response

A healthy immune system depends on complex communication between specialized cell types that detect, alert, and eliminate harmful threats. When these immune signaling pathways break down, the result can... Read more

Microbiology

view channel
Image: MycoMEIA Aspergillus Assay is the first FDA-cleared urine-based test for invasive aspergillosis (Photo courtesy of Pearl Diagnostics)

Urine-Based Assay Diagnoses Common Lung Infection in Immunocompromised People

Invasive Aspergillosis (IA), a life-threatening fungal infection, poses a serious threat to immunocompromised individuals, especially those with hematologic malignancies, transplants, or severe lung diseases.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.